Applying Precision Medicine to the Treatment of Hematologic Diseases 2018

Applying Precision Medicine to the Treatment of Hematologic Diseases is organized by Hemedicus, Inc and will be held on Apr 28, 2018 at Tufts University School of Medicine, Boston, Massachusetts, United States of America.

The target audience for this medical event is Hematologists. This CME Conference has been approved for a maximum of 5.5 AMA PRA Category 1 Credits.

Conference Description:

The proposed activity will highlight the most recent advances in personalizing treatment in various hematologic diseases such as amyloidosis, multiple myeloma, sickle cell anemia, chronic lymphocytic leukemia, myelodysplastic syndrome, B-cell lymphomas and Hodgkin lymphoma. The role of novel therapies such as small molecules and natural killer cells in precision medicine will also be discussed. Overall, the proposed educational agenda will enable attendees to remain abreast of and integrate critical updates in precision medicine for improved treatment and management of hematologic diseases.

Additional details will be posted as soon as they are available.